Abstract
X-Linked adrenoleukodystrophy (X-ALD) is a severe metabolic disorder characterized by the accumulation of very long-chain fatty acids (VLCFAs). Recently, we demonstrated that levels of 25-hydroxycholesterol (25-HC) and cholesterol 25-hydroxylase (CH25H) were found to be elevated in X-ALD. Herein, we report that the exogenous addition of 25-HC significantly reduces C26:0 levels in X-ALD patient-derived fibroblasts and oligodendrocytes differentiated from induced pluripotent stem cells (iPSCs) derived from X-ALD patients. Moreover, 25-HC treatment was found to down-regulate the expression of ELOVL1, a key enzyme for the synthesis of C26. In addition, activation of liver X receptor (LXR), a molecular target of endogenous 25-HC, also reduced C26:0 level. The reduction of C26:0 levels by 25-HC treatment might result, at least partially, from the decrease of ELOVL1 expression as well as the activation of LXR. Our findings could provide a better understanding of the role of 25-HC in X-ALD and useful information to find therapeutic agents to treat X-ALD.
References
Mar 1, 1984·Pediatric Research·I SinghY Kishimoto
Oct 1, 1981·Neurology·H W MoserY Kishimoto
Aug 1, 1994·Neurochemical Research·M RasmussenH W Moser
Sep 9, 1993·The New England Journal of Medicine·P AubourgC Wolf
Sep 5, 1998·The New England Journal of Medicine·I SinghS Pai
Jun 28, 2000·Molecular Genetics and Metabolism·G S PaiI Singh
Jun 23, 2006·Journal of Lipid Research·Yun WangDonald B Jump
Jul 13, 2007·Biochemical and Biophysical Research Communications·Shunlin RenWilliam M Pandak
Nov 28, 2008·Cardiovascular Therapeutics·Jerzy Bełtowski
Jan 22, 2010·The New England Journal of Medicine·Marc EngelenStephan Kemp
Feb 19, 2010·EMBO Molecular Medicine·Rob OfmanStephan Kemp
Apr 10, 2012·Biochimica Et Biophysica Acta·Stephan KempPatrick Aubourg
Jan 1, 2013·Immunity·Mathieu BlancPeter Ghazal
Jan 1, 2013·Immunity·Su-Yang LiuGenhong Cheng
Dec 17, 2014·Biochimica Et Biophysica Acta·Martin J A SchackmannStephan Kemp
Jun 12, 2016·Trends in Molecular Medicine·Owein Guillemot-LegrisGiulio G Muccioli
Jun 18, 2016·Nature Reviews. Endocrinology·Stephan KempMarc Engelen
Oct 26, 2016·Nature Communications·Jiho JangDong-Wook Kim
Mar 21, 2017·Immunity·Chunfeng LiGenhong Cheng
Jan 5, 2018·Journal of Lipid Research·Ying LiuYajun Duan
Aug 10, 2018·Journal of Cellular and Molecular Medicine·Wei OuyangFeng Xu